US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

10.72

+1.8120.31%

Post-market: 10.36-0.3600-3.36%19:59 EST

Volume:87.49K

Turnover:875.38K

Market Cap:9.83M

PE:-0.05

High:10.95

Open:8.60

Low:8.60

Close:8.91

52wk High:357.56

52wk Low:6.08

Shares:916.97K

Float Shares:832.40K

Volume Ratio:0.04

T/O Rate:10.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-236.5200

EPS(LYR):-1,317.4218

ROE:-1763.01%

ROA:-232.54%

PB:6.89

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Top Midday Gainers

MT Newswires Live

TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial

Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138

TransCode Therapeutics Submits IND Amendment for Phase 2a Trial of TTX-MC138 in Colorectal Cancer

Transcode Therapeutics and Quantum Leap Announce Submission of Ind Amendment for Phase 2a Clinical Trial With Ttx-Mc138

THOMSON REUTERS

BRIEF-Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026

Transcode Therapeutics Inc - Ttx-Mc138 Phase 2a Clinical Trial Expected in First Half of 2026 - SEC Filing

THOMSON REUTERS

TransCode Therapeutics Reports Preclinical Success of TTX-MC138 in Glioblastoma Models

TransCode Therapeutics Files Amended 8-K on ABCJ Acquisition

Transcode Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Jack E. Stover

Transcode Therapeutics Expands Leadership With Appointment of Jack E. Stover to Board of Directors

THOMSON REUTERS

Press Release: TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors

Transcode Therapeutics Inc Files for Mixed Shelf of up to $150 Mln – SEC Filing

THOMSON REUTERS

TransCode Therapeutics and Quantum Leap Launch Phase 2a Trial for TTX-MC138 in Colorectal Cancer

Transcode Therapeutics Inc - Phase 2a Trial to Begin in 2026

THOMSON REUTERS

BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer

Transcode Therapeutics Expands Executive Team With Appointment of DR. Michel Janicot as Senior Development Officer

THOMSON REUTERS

Press Release: TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer

TransCode Therapeutics Amends Preferred Stock Designation

TransCode Therapeutics Updates SEC Filing to Report CVR Agreement Effective Date and Change in Rights Agent

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNAZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RNAZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":10.72,"timestamp":1770670800000,"preClose":8.91,"halted":0,"volume":87485,"hourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":10.72,"latestTime":"19:59 EST","volume":2257,"amount":23784.69,"timestamp":1770685151706,"change":-0.36,"changeRate":-0.033582,"amplitude":0.0625},"delay":0,"changeRate":0.20314253647586986,"floatShares":832400,"shares":916968,"eps":-236.52,"marketStatus":"Closed","change":1.81,"latestTime":"02-09 16:00:00 EST","open":8.6,"high":10.95,"low":8.6,"amount":875376.572215,"amplitude":0.263749,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-236.52,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":8.91,"preHourTrading":{"tag":"盘前","latestPrice":8.59,"preClose":8.91,"latestTime":"09:24 EST","volume":1318,"amount":11357.617216,"timestamp":1770647079724,"change":-0.32,"changeRate":-0.035915,"amplitude":0.031425},"postHourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":10.72,"latestTime":"19:59 EST","volume":2257,"amount":23784.69,"timestamp":1770685151706,"change":-0.36,"changeRate":-0.033582,"amplitude":0.0625},"volumeRatio":0.03675},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","floatShares":832400,"roa":"-232.54%","roe":"-1763.01%","lyrEps":-1317.421843,"volumeRatio":0.03675,"shares":916968,"dividePrice":0,"high":10.95,"amplitude":0.263749,"preClose":8.91,"low":8.6,"week52Low":6.0829,"pbRate":"6.89","week52High":357.56,"institutionHeld":0,"latestPrice":10.72,"eps":-236.52,"divideRate":0,"volume":87485,"delay":0,"ttmEps":-236.52,"open":8.6,"prevYearClose":6.83,"prevWeekClose":8.91,"prevMonthClose":9.49,"prevQuarterClose":6.83,"fiveDayClose":9.3,"twentyDayClose":8.01,"sixtyDayClose":9.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RNAZ","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2024-12-04","symbol":"RNAZ","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":33,"toFactor":1,"ratio":33},{"market":"US","date":"2024-01-16","symbol":"RNAZ","defaultRemindTime":1705415400000,"type":"split","dateTimestamp":1705381200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-05-23","symbol":"RNAZ","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2021-08-23","symbol":"RNAZ","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629691200000,"reportTimeType":"","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAZ","date":"2026-02-06","current":-0.045324,"percent":0.600351,"low":-14.365299,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"high":-0.024019,"avg":-1.992692,"sd":3.077384,"marketCap":9142111},"quantilePoints":[{"date":"2021-04-30","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-05-07","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-05-11","current":-14.365299,"twenty":-14.365299,"median":-14.365299,"eighty":-14.365299,"marketCap":33670724},{"date":"2021-06-18","current":-2.6923,"twenty":-14.365299,"median":-14.365299,"eighty":-4.960352,"marketCap":18275252},{"date":"2021-06-22","current":-7.012211,"twenty":-14.365299,"median":-14.365299,"eighty":-5.781096,"marketCap":47598684},{"date":"2021-07-09","current":-9.273649,"twenty":-14.365299,"median":-14.365299,"eighty":-7.012211,"marketCap":62949259},{"date":"2021-07-16","current":-5.64483,"twenty":-14.365299,"median":-10.29042,"eighty":-6.205807,"marketCap":38316940},{"date":"2021-07-23","current":-5.942849,"twenty":-14.365299,"median":-7.012211,"eighty":-5.416933,"marketCap":40339884},{"date":"2021-07-30","current":-5.101383,"twenty":-14.365299,"median":-7.012211,"eighty":-5.101383,"marketCap":34628042},{"date":"2021-08-06","current":-5.574708,"twenty":-14.365299,"median":-6.205807,"eighty":-5.136444,"marketCap":37840953},{"date":"2021-08-13","current":-5.031261,"twenty":-14.365299,"median":-5.811369,"eighty":-5.136444,"marketCap":34152055},{"date":"2021-08-20","current":-4.768303,"twenty":-14.365299,"median":-5.714952,"eighty":-5.066322,"marketCap":32367105},{"date":"2021-08-27","current":-10.254026,"twenty":-14.365299,"median":-5.811369,"eighty":-5.083853,"marketCap":39886816},{"date":"2021-09-03","current":-8.929933,"twenty":-11.30719,"median":-6.205807,"eighty":-5.09963,"marketCap":34736270},{"date":"2021-09-10","current":-9.261701,"twenty":-10.464659,"median":-7.012211,"eighty":-5.101032,"marketCap":36026802},{"date":"2021-09-17","current":-8.037833,"twenty":-10.121716,"median":-7.012211,"eighty":-5.129432,"marketCap":31266117},{"date":"2021-09-24","current":-12.106366,"twenty":-10.464659,"median":-7.99392,"eighty":-5.178518,"marketCap":47092176},{"date":"2021-10-01","current":-9.460165,"twenty":-10.702816,"median":-8.236298,"eighty":-5.217085,"marketCap":36798804},{"date":"2021-10-08","current":-9.096313,"twenty":-10.445875,"median":-8.533995,"eighty":-5.308243,"marketCap":35383466},{"date":"2021-10-15","current":-10.650956,"twenty":-10.598032,"median":-8.782076,"eighty":-5.399402,"marketCap":41430822},{"date":"2021-10-22","current":-9.096313,"twenty":-10.598032,"median":-9.096313,"eighty":-5.459006,"marketCap":35383466},{"date":"2021-10-29","current":-9.360933,"twenty":-10.558339,"median":-9.12939,"eighty":-5.483549,"marketCap":36412803},{"date":"2021-11-05","current":-10.849421,"twenty":-10.750188,"median":-9.228623,"eighty":-5.543153,"marketCap":42202825},{"date":"2021-11-12","current":-9.757863,"twenty":-10.750188,"median":-9.261701,"eighty":-5.557177,"marketCap":37956809},{"date":"2021-11-19","current":-7.259636,"twenty":-10.670802,"median":-9.228623,"eighty":-5.571202,"marketCap":35177810},{"date":"2021-11-26","current":-7.153268,"twenty":-10.611263,"median":-9.162468,"eighty":-5.616781,"marketCap":34662385},{"date":"2021-12-03","current":-7.17986,"twenty":-10.564954,"median":-9.096313,"eighty":-5.686903,"marketCap":34791241},{"date":"2021-12-10","current":-7.153268,"twenty":-10.472337,"median":-8.831693,"eighty":-5.735989,"marketCap":34662385},{"date":"2021-12-17","current":-6.860756,"twenty":-10.419413,"median":-8.60015,"eighty":-5.781568,"marketCap":33244964},{"date":"2021-12-23","current":-7.126676,"twenty":-10.353258,"median":-8.451301,"eighty":-5.809616,"marketCap":34533528},{"date":"2021-12-31","current":-6.754387,"twenty":-10.227564,"median":-8.037833,"eighty":-5.869221,"marketCap":32729538},{"date":"2022-01-07","current":-6.461874,"twenty":-10.148178,"median":-7.959179,"eighty":-6.048032,"marketCap":31312117},{"date":"2022-01-14","current":-6.674611,"twenty":-10.075407,"median":-7.764886,"eighty":-6.28696,"marketCap":32342968},{"date":"2022-01-21","current":-5.398191,"twenty":-10.035714,"median":-7.658518,"eighty":-5.961559,"marketCap":26157859},{"date":"2022-01-28","current":-6.036401,"twenty":-9.943097,"median":-7.405893,"eighty":-5.890049,"marketCap":29250414},{"date":"2022-02-04","current":-6.435282,"twenty":-9.890173,"median":-7.259636,"eighty":-5.961559,"marketCap":31183260},{"date":"2022-02-11","current":-5.517856,"twenty":-9.883557,"median":-7.233044,"eighty":-5.961559,"marketCap":26737713},{"date":"2022-02-18","current":-5.850257,"twenty":-9.85048,"median":-7.17986,"eighty":-5.855575,"marketCap":28348419},{"date":"2022-02-25","current":-5.797072,"twenty":-9.824018,"median":-7.17986,"eighty":-5.802604,"marketCap":28090706},{"date":"2022-03-04","current":-5.956625,"twenty":-9.824018,"median":-7.139972,"eighty":-5.750013,"marketCap":28863844},{"date":"2022-03-11","current":-6.328914,"twenty":-9.757863,"median":-7.012211,"eighty":-5.750013,"marketCap":30667835},{"date":"2022-03-18","current":-6.780979,"twenty":-9.757863,"median":-7.012211,"eighty":-5.743888,"marketCap":32858394},{"date":"2022-03-25","current":-6.54165,"twenty":-9.757863,"median":-6.91394,"eighty":-5.750013,"marketCap":31698686},{"date":"2022-04-01","current":-5.336521,"twenty":-9.757863,"median":-6.953828,"eighty":-5.743888,"marketCap":36519944},{"date":"2022-04-08","current":-5.713661,"twenty":-9.757863,"median":-6.91394,"eighty":-5.690704,"marketCap":39100859},{"date":"2022-04-14","current":-5.406292,"twenty":-9.757863,"median":-6.887347,"eighty":-5.660256,"marketCap":36997413},{"date":"2022-04-22","current":-5.072524,"twenty":-9.704939,"median":-6.840812,"eighty":-5.571315,"marketCap":34713304},{"date":"2022-04-29","current":-5.147952,"twenty":-9.58586,"median":-6.780979,"eighty":-5.549313,"marketCap":35229487},{"date":"2022-05-06","current":-5.214864,"twenty":-9.480012,"median":-6.767683,"eighty":-5.483549,"marketCap":35687393},{"date":"2022-05-13","current":-4.266707,"twenty":-9.460165,"median":-6.754387,"eighty":-5.429601,"marketCap":29198776},{"date":"2022-05-20","current":-4.475575,"twenty":-9.407241,"median":-6.674611,"eighty":-5.404672,"marketCap":26084240},{"date":"2022-05-27","current":-4.074778,"twenty":-9.39401,"median":-6.674611,"eighty":-5.336521,"marketCap":23748338},{"date":"2022-06-03","current":-3.941178,"twenty":-9.374164,"median":-6.621427,"eighty":-5.324634,"marketCap":22969704},{"date":"2022-06-10","current":-3.629447,"twenty":-9.360933,"median":-6.54165,"eighty":-5.272407,"marketCap":21152891},{"date":"2022-06-17","current":-2.671985,"twenty":-9.308563,"median":-6.488466,"eighty":-5.22381,"marketCap":15572680},{"date":"2022-06-24","current":-2.850118,"twenty":-9.26887,"median":-6.461874,"eighty":-5.199367,"marketCap":16610859},{"date":"2022-07-01","current":-2.761052,"twenty":-9.261701,"median":-6.435282,"eighty":-5.137471,"marketCap":16091770},{"date":"2022-07-08","current":-3.094827,"twenty":-9.261701,"median":-6.40869,"eighty":-5.087008,"marketCap":18037057},{"date":"2022-07-15","current":-2.939184,"twenty":-9.261701,"median":-6.328914,"eighty":-4.996097,"marketCap":17129948},{"date":"2022-07-22","current":-2.872384,"twenty":-9.255085,"median":-6.227473,"eighty":-4.960352,"marketCap":16740631},{"date":"2022-07-29","current":-3.161849,"twenty":-9.222007,"median":-6.116177,"eighty":-4.771809,"marketCap":18427672},{"date":"2022-08-05","current":-3.195249,"twenty":-9.18893,"median":-6.116177,"eighty":-4.618082,"marketCap":18622330},{"date":"2022-08-12","current":-2.872384,"twenty":-9.149237,"median":-6.036401,"eighty":-4.456649,"marketCap":16740631},{"date":"2022-08-19","current":-1.241956,"twenty":-9.096313,"median":-6.023105,"eighty":-4.180624,"marketCap":16481087},{"date":"2022-08-26","current":-1.095268,"twenty":-9.096313,"median":-5.942849,"eighty":-4.079231,"marketCap":14534502},{"date":"2022-09-02","current":-1.163722,"twenty":-9.063037,"median":-5.890145,"eighty":-3.972352,"marketCap":15442908},{"date":"2022-09-09","current":-1.105047,"twenty":-8.929933,"median":-5.850257,"eighty":-3.629447,"marketCap":14664274},{"date":"2022-09-16","current":-1.085489,"twenty":-8.831693,"median":-5.802604,"eighty":-3.228649,"marketCap":14404729},{"date":"2022-09-23","current":-1.007256,"twenty":-8.73246,"median":-5.773542,"eighty":-3.161849,"marketCap":13366551},{"date":"2022-09-30","current":-1.07571,"twenty":-8.666305,"median":-5.743888,"eighty":-3.094827,"marketCap":14274957},{"date":"2022-10-07","current":-1.19306,"twenty":-8.533995,"median":-5.702183,"eighty":-3.02825,"marketCap":15832225},{"date":"2022-10-14","current":-1.086467,"twenty":-8.533995,"median":-5.675947,"eighty":-2.983717,"marketCap":14417706},{"date":"2022-10-21","current":-1.065931,"twenty":-8.368608,"median":-5.641175,"eighty":-2.939184,"marketCap":14145185},{"date":"2022-10-28","current":-0.745956,"twenty":-8.103988,"median":-5.574708,"eighty":-2.894651,"marketCap":9899034},{"date":"2022-11-04","current":-0.567192,"twenty":-8.037833,"median":-5.55746,"eighty":-2.872384,"marketCap":7526795},{"date":"2022-11-11","current":-0.513407,"twenty":-8.004215,"median":-5.517856,"eighty":-2.827851,"marketCap":6813047},{"date":"2022-11-18","current":-0.451599,"twenty":-7.99392,"median":-5.495807,"eighty":-2.761052,"marketCap":6877934},{"date":"2022-11-25","current":-0.416494,"twenty":-7.938335,"median":-5.469022,"eighty":-2.688237,"marketCap":6343271},{"date":"2022-12-02","current":-0.366392,"twenty":-7.856382,"median":-5.430806,"eighty":-1.257602,"marketCap":5580210},{"date":"2022-12-09","current":-0.458075,"twenty":-7.779782,"median":-5.420196,"eighty":-1.200883,"marketCap":6976560},{"date":"2022-12-16","current":-0.366392,"twenty":-7.743612,"median":-5.398191,"eighty":-1.173502,"marketCap":5580210},{"date":"2022-12-23","current":-0.30794,"twenty":-7.674473,"median":-5.355378,"eighty":-1.163722,"marketCap":4689972},{"date":"2022-12-30","current":-0.573446,"twenty":-7.610652,"median":-5.336521,"eighty":-1.150031,"marketCap":8733678},{"date":"2023-01-06","current":-0.540811,"twenty":-7.546831,"median":-5.323472,"eighty":-1.138297,"marketCap":8236650},{"date":"2023-01-13","current":-0.521469,"twenty":-7.477691,"median":-5.27995,"eighty":-1.124606,"marketCap":7942067},{"date":"2023-01-20","current":-0.582393,"twenty":-7.419189,"median":-5.261093,"eighty":-1.107003,"marketCap":8869939},{"date":"2023-01-27","current":-0.651837,"twenty":-7.312821,"median":-5.242595,"eighty":-1.095268,"marketCap":9927584},{"date":"2023-02-03","current":-0.533484,"twenty":-7.302184,"median":-5.214864,"eighty":-1.095268,"marketCap":8125046},{"date":"2023-02-10","current":-0.413256,"twenty":-7.259636,"median":-5.168494,"eighty":-1.077744,"marketCap":6293958},{"date":"2023-02-17","current":-0.545246,"twenty":-7.259636,"median":-5.139011,"eighty":-1.058107,"marketCap":8304190},{"date":"2023-02-24","current":-0.446753,"twenty":-7.259636,"median":-5.101383,"eighty":-1.017035,"marketCap":6804119},{"date":"2023-03-03","current":-0.477921,"twenty":-7.259636,"median":-5.078188,"eighty":-0.987697,"marketCap":7278825},{"date":"2023-03-10","current":-0.414545,"twenty":-7.259636,"median":-5.031261,"eighty":-0.742156,"marketCap":6313590},{"date":"2023-03-17","current":-0.336207,"twenty":-7.206452,"median":-4.969511,"eighty":-0.639737,"marketCap":5120495},{"date":"2023-03-24","current":-0.331428,"twenty":-7.206452,"median":-4.960352,"eighty":-0.630535,"marketCap":5047707},{"date":"2023-03-31","current":-0.351688,"twenty":-7.17986,"median":-4.820895,"eighty":-0.589635,"marketCap":5356266},{"date":"2023-04-06","current":-0.45174,"twenty":-7.17986,"median":-4.766672,"eighty":-0.576377,"marketCap":6880072},{"date":"2023-04-14","current":-0.359623,"twenty":-7.17986,"median":-4.653708,"eighty":-0.562385,"marketCap":6316770},{"date":"2023-04-21","current":-0.3153,"twenty":-7.158586,"median":-4.508975,"eighty":-0.54538,"marketCap":5538236},{"date":"2023-04-28","current":-0.301157,"twenty":-7.153268,"median":-4.453309,"eighty":-0.536142,"marketCap":5289807},{"date":"2023-05-05","current":-0.280887,"twenty":-7.131994,"median":-4.257226,"eighty":-0.526923,"marketCap":4933777},{"date":"2023-05-12","current":-0.26233,"twenty":-7.07881,"median":-4.141578,"eighty":-0.517222,"marketCap":4607813},{"date":"2023-05-19","current":-0.244735,"twenty":-7.033024,"median":-4.108178,"eighty":-0.502627,"marketCap":4628383},{"date":"2023-05-26","current":-0.218865,"twenty":-7.012211,"median":-4.052511,"eighty":-0.493236,"marketCap":4139139},{"date":"2023-06-02","current":-0.177519,"twenty":-7.012211,"median":-4.007978,"eighty":-0.484966,"marketCap":3357207},{"date":"2023-06-09","current":-0.429482,"twenty":-7.012211,"median":-3.952311,"eighty":-0.474116,"marketCap":8122289},{"date":"2023-06-16","current":-0.396344,"twenty":-7.012211,"median":-3.629447,"eighty":-0.464845,"marketCap":7495590},{"date":"2023-06-23","current":-0.238101,"twenty":-7.001114,"median":-3.339982,"eighty":-0.453859,"marketCap":4502917},{"date":"2023-06-30","current":-0.230481,"twenty":-6.961806,"median":-3.228649,"eighty":-0.448691,"marketCap":4358824},{"date":"2023-07-07","current":-0.2181,"twenty":-6.91394,"median":-3.195249,"eighty":-0.438648,"marketCap":4124672},{"date":"2023-07-13","current":-0.26953,"twenty":-6.91394,"median":-3.161849,"eighty":-0.429701,"marketCap":5097302},{"date":"2023-07-21","current":-0.235243,"twenty":-6.91394,"median":-3.106183,"eighty":-0.417426,"marketCap":4448882},{"date":"2023-07-28","current":-0.225719,"twenty":-6.91394,"median":-3.072783,"eighty":-0.413256,"marketCap":4268765},{"date":"2023-08-04","current":-0.17429,"twenty":-6.887347,"median":-3.050516,"eighty":-0.400475,"marketCap":3296135},{"date":"2023-08-11","current":-0.160004,"twenty":-6.887347,"median":-3.02825,"eighty":-0.38961,"marketCap":3025960},{"date":"2023-08-18","current":-0.157995,"twenty":-6.860756,"median":-2.972583,"eighty":-0.383263,"marketCap":2935902},{"date":"2023-08-25","current":-0.188589,"twenty":-6.820867,"median":-2.96145,"eighty":-0.363636,"marketCap":3504416},{"date":"2023-09-01","current":-0.158066,"twenty":-6.780979,"median":-2.939184,"eighty":-0.359623,"marketCap":2937227},{"date":"2023-09-08","current":-0.125363,"twenty":-6.780979,"median":-2.905784,"eighty":-0.354845,"marketCap":2329525},{"date":"2023-09-15","current":-0.080668,"twenty":-6.780979,"median":-2.872384,"eighty":-0.351688,"marketCap":1498998},{"date":"2023-09-22","current":-0.07597,"twenty":-6.780979,"median":-2.870157,"eighty":-0.348588,"marketCap":1411692},{"date":"2023-09-29","current":-0.062714,"twenty":-6.759705,"median":-2.827851,"eighty":-0.342044,"marketCap":1165370},{"date":"2023-10-06","current":-0.071025,"twenty":-6.754387,"median":-2.816718,"eighty":-0.335629,"marketCap":1319806},{"date":"2023-10-13","current":-0.069464,"twenty":-6.754387,"median":-2.761052,"eighty":-0.331116,"marketCap":1290799},{"date":"2023-10-20","current":-0.062018,"twenty":-6.722231,"median":-2.715542,"eighty":-0.328027,"marketCap":1152437},{"date":"2023-10-27","current":-0.064937,"twenty":-6.706276,"median":-2.682142,"eighty":-0.320027,"marketCap":1206680},{"date":"2023-11-03","current":-0.394873,"twenty":-6.674611,"median":-1.281073,"eighty":-0.325669,"marketCap":7337632},{"date":"2023-11-10","current":-0.374108,"twenty":-6.674611,"median":-1.222398,"eighty":-0.328975,"marketCap":6951778},{"date":"2023-11-17","current":-0.266701,"twenty":-6.674611,"median":-1.202839,"eighty":-0.325669,"marketCap":5225374},{"date":"2023-11-24","current":-0.246083,"twenty":-6.674611,"median":-1.19306,"eighty":-0.313052,"marketCap":4821413},{"date":"2023-12-01","current":-0.252341,"twenty":-6.648019,"median":-1.173502,"eighty":-0.301157,"marketCap":4944008},{"date":"2023-12-08","current":-0.257476,"twenty":-6.621427,"median":-1.163722,"eighty":-0.294624,"marketCap":5044616},{"date":"2023-12-15","current":-0.216613,"twenty":-6.594835,"median":-1.158832,"eighty":-0.284581,"marketCap":4244003},{"date":"2023-12-22","current":-0.21277,"twenty":-6.54165,"median":-1.144164,"eighty":-0.278188,"marketCap":4168710},{"date":"2023-12-29","current":-0.219174,"twenty":-6.54165,"median":-1.144164,"eighty":-0.276419,"marketCap":4294198},{"date":"2024-01-05","current":-0.187022,"twenty":-6.536278,"median":-1.134385,"eighty":-0.272473,"marketCap":3664249},{"date":"2024-01-12","current":-0.174212,"twenty":-6.509527,"median":-1.129495,"eighty":-0.267111,"marketCap":3413273},{"date":"2024-01-19","current":-0.034907,"twenty":-6.488466,"median":-1.124606,"eighty":-0.258101,"marketCap":683918},{"date":"2024-01-26","current":-0.245163,"twenty":-6.461874,"median":-1.105047,"eighty":-0.25511,"marketCap":4803378},{"date":"2024-02-02","current":-0.228731,"twenty":-6.461874,"median":-1.100157,"eighty":-0.252387,"marketCap":4481445},{"date":"2024-02-09","current":-0.226015,"twenty":-6.435282,"median":-1.095268,"eighty":-0.249824,"marketCap":4428227},{"date":"2024-02-16","current":-0.222025,"twenty":-6.435282,"median":-1.095268,"eighty":-0.245163,"marketCap":4350044},{"date":"2024-02-23","current":-0.243453,"twenty":-6.435282,"median":-1.085978,"eighty":-0.244479,"marketCap":4769871},{"date":"2024-03-01","current":-0.236277,"twenty":-6.414008,"median":-1.075808,"eighty":-0.242065,"marketCap":4629272},{"date":"2024-03-08","current":-0.244794,"twenty":-6.40869,"median":-1.07082,"eighty":-0.241215,"marketCap":4796151},{"date":"2024-03-15","current":-0.231347,"twenty":-6.37678,"median":-1.054196,"eighty":-0.238072,"marketCap":4532691},{"date":"2024-03-22","current":-0.228698,"twenty":-6.336892,"median":-1.014394,"eighty":-0.236326,"marketCap":4480788},{"date":"2024-03-28","current":-0.227658,"twenty":-6.312959,"median":-1.007207,"eighty":-0.235241,"marketCap":4460421},{"date":"2024-04-05","current":-0.240859,"twenty":-6.270412,"median":-0.835033,"eighty":-0.235103,"marketCap":4466991},{"date":"2024-04-12","current":-0.200193,"twenty":-6.223139,"median":-0.744056,"eighty":-0.234734,"marketCap":3712797},{"date":"2024-04-19","current":-0.157211,"twenty":-6.152029,"median":-0.657161,"eighty":-0.233326,"marketCap":2915642},{"date":"2024-04-26","current":-0.164413,"twenty":-6.116177,"median":-0.637734,"eighty":-0.231025,"marketCap":3049227},{"date":"2024-05-03","current":-0.232846,"twenty":-6.116177,"median":-0.632224,"eighty":-0.230356,"marketCap":4318393},{"date":"2024-05-10","current":-0.438028,"twenty":-6.116177,"median":-0.613536,"eighty":-0.230455,"marketCap":8123710},{"date":"2024-05-17","current":-0.316863,"twenty":-6.116177,"median":-0.589635,"eighty":-0.230455,"marketCap":5404405},{"date":"2024-05-24","current":-0.539673,"twenty":-6.100222,"median":-0.579751,"eighty":-0.230518,"marketCap":9204653},{"date":"2024-05-31","current":-0.636737,"twenty":-6.068311,"median":-0.584621,"eighty":-0.230864,"marketCap":10860166},{"date":"2024-06-07","current":-0.520261,"twenty":-6.036401,"median":-0.582393,"eighty":-0.231361,"marketCap":8873551},{"date":"2024-06-14","current":-0.45814,"twenty":-6.036401,"median":-0.573446,"eighty":-0.231448,"marketCap":7814022},{"date":"2024-06-21","current":-0.396019,"twenty":-6.036401,"median":-0.567192,"eighty":-0.231716,"marketCap":6754494},{"date":"2024-06-28","current":-0.392137,"twenty":-6.025764,"median":-0.562969,"eighty":-0.231716,"marketCap":6688273},{"date":"2024-07-05","current":-0.337043,"twenty":-5.999172,"median":-0.562107,"eighty":-0.231942,"marketCap":5748604},{"date":"2024-07-12","current":-0.37061,"twenty":-5.95387,"median":-0.549375,"eighty":-0.233157,"marketCap":6321122},{"date":"2024-07-15","current":-0.365073,"twenty":-5.951115,"median":-0.545413,"eighty":-0.233467,"marketCap":6226668},{"date":"2024-08-02","current":-0.279596,"twenty":-5.948359,"median":-0.54533,"eighty":-0.233778,"marketCap":4768774},{"date":"2024-08-09","current":-0.261577,"twenty":-5.935159,"median":-0.540811,"eighty":-0.23458,"marketCap":4461446},{"date":"2024-08-16","current":-0.241071,"twenty":-5.914078,"median":-0.535146,"eighty":-0.23458,"marketCap":4316414},{"date":"2024-08-23","current":-0.268168,"twenty":-5.887486,"median":-0.528286,"eighty":-0.2347,"marketCap":4801579},{"date":"2024-08-30","current":-0.268843,"twenty":-5.860894,"median":-0.524747,"eighty":-0.23472,"marketCap":4813665},{"date":"2024-09-06","current":-0.265178,"twenty":-5.850257,"median":-0.520013,"eighty":-0.2347,"marketCap":4748055},{"date":"2024-09-13","current":-0.243964,"twenty":-5.838208,"median":-0.51569,"eighty":-0.234714,"marketCap":4368211},{"date":"2024-09-20","current":-0.3645,"twenty":-5.813123,"median":-0.509454,"eighty":-0.234734,"marketCap":6526418},{"date":"2024-09-27","current":-0.593228,"twenty":-5.800391,"median":-0.508517,"eighty":-0.234734,"marketCap":10621832},{"date":"2024-10-04","current":-0.591107,"twenty":-5.797072,"median":-0.509454,"eighty":-0.234734,"marketCap":10583848},{"date":"2024-10-11","current":-0.70335,"twenty":-5.778248,"median":-0.513407,"eighty":-0.234801,"marketCap":12593570},{"date":"2024-10-18","current":-0.577607,"twenty":-5.747563,"median":-0.519765,"eighty":-0.235036,"marketCap":10342129},{"date":"2024-10-25","current":-0.6264,"twenty":-5.743888,"median":-0.521196,"eighty":-0.235239,"marketCap":11215771},{"date":"2024-10-31","current":-0.486,"twenty":-5.738101,"median":-0.521469,"eighty":-0.235434,"marketCap":8701891},{"date":"2024-11-08","current":-0.453214,"twenty":-5.714694,"median":-0.520013,"eighty":-0.236212,"marketCap":8114859},{"date":"2024-11-15","current":-0.337403,"twenty":-5.70907,"median":-0.51569,"eighty":-0.236289,"marketCap":6041253},{"date":"2024-11-22","current":-0.439549,"twenty":-5.690704,"median":-0.509454,"eighty":-0.236554,"marketCap":6560950},{"date":"2024-11-29","current":-0.402534,"twenty":-5.690704,"median":-0.499775,"eighty":-0.237417,"marketCap":6008448},{"date":"2024-12-06","current":-0.30495,"twenty":-5.675947,"median":-0.496415,"eighty":-0.237718,"marketCap":4551848},{"date":"2024-12-13","current":-0.252723,"twenty":-5.664112,"median":-0.493246,"eighty":-0.237958,"marketCap":3772279},{"date":"2024-12-20","current":-0.134949,"twenty":-5.64483,"median":-0.486,"eighty":-0.236338,"marketCap":2014323},{"date":"2024-12-27","current":-0.136351,"twenty":-5.638982,"median":-0.481763,"eighty":-0.235767,"marketCap":2035251},{"date":"2025-01-03","current":-0.123732,"twenty":-5.621565,"median":-0.477921,"eighty":-0.234835,"marketCap":1846899},{"date":"2025-01-10","current":-0.120227,"twenty":-5.59644,"median":-0.477553,"eighty":-0.234734,"marketCap":1794579},{"date":"2025-01-17","current":-0.117423,"twenty":-5.567922,"median":-0.472095,"eighty":-0.233467,"marketCap":1752723},{"date":"2025-01-24","current":-0.192784,"twenty":-5.557744,"median":-0.467653,"eighty":-0.231448,"marketCap":2877605},{"date":"2025-01-31","current":-0.375492,"twenty":-5.557631,"median":-0.466511,"eighty":-0.231716,"marketCap":5604804},{"date":"2025-02-07","current":-0.530353,"twenty":-5.557177,"median":-0.46549,"eighty":-0.231942,"marketCap":7916351},{"date":"2025-02-14","current":-0.497235,"twenty":-5.549313,"median":-0.466511,"eighty":-0.233157,"marketCap":7422014},{"date":"2025-02-21","current":-0.437063,"twenty":-5.517856,"median":-0.466511,"eighty":-0.234399,"marketCap":6523853},{"date":"2025-02-28","current":-0.117545,"twenty":-5.50456,"median":-0.464726,"eighty":-0.231716,"marketCap":1754547},{"date":"2025-03-07","current":-0.07883,"twenty":-5.50456,"median":-0.459919,"eighty":-0.230702,"marketCap":1176660},{"date":"2025-03-14","current":-0.034611,"twenty":-5.487055,"median":-0.45816,"eighty":-0.230267,"marketCap":516616},{"date":"2025-03-21","current":-0.035917,"twenty":-5.469524,"median":-0.455272,"eighty":-0.228053,"marketCap":536111},{"date":"2025-03-28","current":-0.813147,"twenty":-5.46852,"median":-0.454243,"eighty":-0.227692,"marketCap":12137494},{"date":"2025-04-04","current":-0.722763,"twenty":-5.46852,"median":-0.45814,"eighty":-0.227692,"marketCap":10788365},{"date":"2025-04-11","current":-0.623309,"twenty":-5.430806,"median":-0.459919,"eighty":-0.228053,"marketCap":9303856},{"date":"2025-04-17","current":-0.496779,"twenty":-5.425988,"median":-0.463616,"eighty":-0.228569,"marketCap":8323520},{"date":"2025-04-25","current":-0.55724,"twenty":-5.423723,"median":-0.459919,"eighty":-0.228724,"marketCap":9336534},{"date":"2025-05-02","current":-0.785708,"twenty":-5.418238,"median":-0.464726,"eighty":-0.228973,"marketCap":13164513},{"date":"2025-05-09","current":-0.487863,"twenty":-5.40842,"median":-0.466511,"eighty":-0.23002,"marketCap":8174135},{"date":"2025-05-16","current":-0.249953,"twenty":-5.399811,"median":-0.467234,"eighty":-0.230385,"marketCap":6377185},{"date":"2025-05-23","current":-0.248972,"twenty":-5.388064,"median":-0.465905,"eighty":-0.230022,"marketCap":6352176},{"date":"2025-05-30","current":-0.225447,"twenty":-5.378754,"median":-0.464376,"eighty":-0.228718,"marketCap":5751971},{"date":"2025-06-06","current":-0.235903,"twenty":-5.351607,"median":-0.459919,"eighty":-0.228718,"marketCap":6018729},{"date":"2025-06-13","current":-0.235413,"twenty":-5.336521,"median":-0.45814,"eighty":-0.228912,"marketCap":6006224},{"date":"2025-06-20","current":-0.228061,"twenty":-5.336521,"median":-0.455272,"eighty":-0.228316,"marketCap":5818660},{"date":"2025-06-27","current":-0.26825,"twenty":-5.333625,"median":-0.451995,"eighty":-0.228711,"marketCap":6844011},{"date":"2025-07-03","current":-0.276091,"twenty":-5.326957,"median":-0.451599,"eighty":-0.228791,"marketCap":7044080},{"date":"2025-07-11","current":-0.294062,"twenty":-5.313893,"median":-0.446753,"eighty":-0.229035,"marketCap":7502571},{"date":"2025-07-18","current":-0.328369,"twenty":-5.295036,"median":-0.443773,"eighty":-0.22914,"marketCap":8377870},{"date":"2025-07-25","current":-0.359437,"twenty":-5.27995,"median":-0.438727,"eighty":-0.229679,"marketCap":9170513},{"date":"2025-08-01","current":-0.362704,"twenty":-5.276179,"median":-0.438196,"eighty":-0.230297,"marketCap":9253881},{"date":"2025-08-08","current":-0.348,"twenty":-5.261093,"median":-0.437433,"eighty":-0.230428,"marketCap":8878723},{"date":"2025-08-15","current":-0.36107,"twenty":-5.261093,"median":-0.435462,"eighty":-0.230493,"marketCap":9212197},{"date":"2025-08-22","current":-0.319249,"twenty":-5.253694,"median":-0.433115,"eighty":-0.230574,"marketCap":7853293},{"date":"2025-08-29","current":-0.334839,"twenty":-5.223953,"median":-0.429592,"eighty":-0.230831,"marketCap":8236788},{"date":"2025-09-05","current":-0.355851,"twenty":-5.223379,"median":-0.426621,"eighty":-0.231347,"marketCap":8753671},{"date":"2025-09-12","current":-0.379574,"twenty":-5.214864,"median":-0.418933,"eighty":-0.231381,"marketCap":9337249},{"date":"2025-09-19","current":-0.380591,"twenty":-5.214864,"median":-0.417216,"eighty":-0.231655,"marketCap":9362260},{"date":"2025-09-26","current":-0.336194,"twenty":-5.189036,"median":-0.415471,"eighty":-0.231716,"marketCap":8270135},{"date":"2025-10-03","current":-0.358562,"twenty":-5.147952,"median":-0.413901,"eighty":-0.231716,"marketCap":8820366},{"date":"2025-10-10","current":-0.500903,"twenty":-5.147952,"median":-0.414143,"eighty":-0.232846,"marketCap":12321834},{"date":"2025-10-17","current":-0.505647,"twenty":-5.139011,"median":-0.415392,"eighty":-0.233289,"marketCap":12438550},{"date":"2025-10-24","current":-0.445322,"twenty":-5.136444,"median":-0.417006,"eighty":-0.234399,"marketCap":10954594},{"date":"2025-10-31","current":-0.371102,"twenty":-5.101383,"median":-0.417216,"eighty":-0.2347,"marketCap":9128828},{"date":"2025-11-07","current":-0.314843,"twenty":-5.09963,"median":-0.415471,"eighty":-0.2347,"marketCap":7744915},{"date":"2025-11-14","current":-0.285359,"twenty":-5.083853,"median":-0.414344,"eighty":-0.234734,"marketCap":7019610},{"date":"2025-11-21","current":-0.263004,"twenty":-5.072524,"median":-0.413256,"eighty":-0.234734,"marketCap":7136326},{"date":"2025-11-28","current":-0.313948,"twenty":-5.067562,"median":-0.411836,"eighty":-0.234734,"marketCap":8518632},{"date":"2025-12-05","current":-0.291836,"twenty":-5.038273,"median":-0.403424,"eighty":-0.234734,"marketCap":7918660},{"date":"2025-12-12","current":-0.352135,"twenty":-4.996097,"median":-0.40212,"eighty":-0.234868,"marketCap":9554806},{"date":"2025-12-19","current":-0.265284,"twenty":-4.980397,"median":-0.400432,"eighty":-0.23517,"marketCap":7198198},{"date":"2025-12-26","current":-0.251091,"twenty":-4.967679,"median":-0.398908,"eighty":-0.235241,"marketCap":6813072},{"date":"2026-01-02","current":-0.230813,"twenty":-4.960352,"median":-0.396262,"eighty":-0.234801,"marketCap":6262850},{"date":"2026-01-09","current":-0.267986,"twenty":-4.960352,"median":-0.395503,"eighty":-0.235024,"marketCap":7271508},{"date":"2026-01-16","current":-0.2984,"twenty":-4.925606,"median":-0.392535,"eighty":-0.235219,"marketCap":8096774},{"date":"2026-01-23","current":-0.314959,"twenty":-4.86998,"median":-0.391393,"eighty":-0.235238,"marketCap":8546085},{"date":"2026-01-30","current":-0.354076,"twenty":-4.841932,"median":-0.390649,"eighty":-0.235277,"marketCap":9607469},{"date":"2026-02-06","current":-0.336926,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"marketCap":9142111}],"updateTime":1770696038464},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609586424","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2609586424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609586424?lang=en_us&edition=fundamental","pubTime":"2026-02-06 03:30","pubTimestamp":1770319845,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) reported Thursday the submission to the US Food and Drug Administration of an investigational new drug application amendment for a phase 2a trial with its lead therapeuti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ1G4Q59.USD","LU1037948541.HKD","LU1814569148.SGD","LU1506573853.SGD","LU0205194284.USD","LU0868494708.USD","LU2112291526.USD","BK4585","LU0965509010.AUD","LU0861579265.USD","RRX","LU1061106388.HKD","LU0965509283.SGD","LU0965508806.USD","MCK","LU0203347892.USD","LU1057294990.SGD","LU2089984988.USD","BK4175","LU0251131958.USD","LU0942090050.USD","LU0314106906.USD","BK4533","LU1983260115.SGD","LU2324357040.USD","BK4139","LU1934455277.USD","LU0205193047.USD","LU1169589451.USD","LU0965509101.SGD","LU1430594728.SGD","LU0251142724.SGD","LU1366192091.USD","LU0274383776.USD","LU0122379950.USD","LU1169590202.USD","LU2468319806.SGD","LU0432979614.USD","RNAZ","LU0048573561.USD","LU0203345920.USD","LU1585245621.USD","LU1023059063.AUD","IE00BKVL7J92.USD","LU0868494617.USD","LU0742534661.SGD","BK4588","LU1934455194.USD","BK4539","LU1934455863.HKD"],"gpt_icon":0},{"id":"2609055723","title":"TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2609055723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609055723?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:39","pubTimestamp":1770298787,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has provided an update. On February 5, 2026, TransCode Therapeutics, in collaboration with Quantum Leap Healthca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-advances-phase-2a-colorectal-cancer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-advances-phase-2a-colorectal-cancer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2609036913","title":"Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138","url":"https://stock-news.laohu8.com/highlight/detail?id=2609036913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609036913?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:12","pubTimestamp":1770297136,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ), in collaboration with Quantum Leap Healthcare Collaborative, announced the submission to the U.S. FDA of an Investig...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-quantum-leap-submit-ind-for-phase-2a-trial-of-ttx-mc138-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-quantum-leap-submit-ind-for-phase-2a-trial-of-ttx-mc138-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","XLV","XBI","BK4007","BK4139","LENZ","BK4588","BK4539","BK4581","RNAZ","BK4585","LABU"],"gpt_icon":0},{"id":"2609308909","title":"TransCode Therapeutics Submits IND Amendment for Phase 2a Trial of TTX-MC138 in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308909?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:05","pubTimestamp":1770296732,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. announced the submission of an Investigational New Drug  application amendment to the U.S. Food and Drug Administration  for a planned Phase 2a clinical trial of its lead therapeutic candidate, TTX-MC138. The trial, focused on colorectal cancer patients with positive markers for circulating tumor DNA, will be conducted in collaboration with Quantum Leap Healthcare Collaborative within the PRE-I-SPY program. The Phase 2a trial is expected to enroll up to 45 patients and will be led by Dr. Paula Pohlmann of MD Anderson Cancer Center.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 05, 2026, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL4wsdsm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"gpt_icon":0},{"id":"2609308526","title":"Transcode Therapeutics and Quantum Leap Announce Submission of Ind Amendment for Phase 2a Clinical Trial With Ttx-Mc138","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308526?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:04","pubTimestamp":1770296640,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nTUA2FQWXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2601813849","title":"BRIEF-Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601813849?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:14","pubTimestamp":1767708873,"startTime":"0","endTime":"0","summary":"BRIEF-Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026 Jan 6  - Transcode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS INC - TTX-MC138 PHASE 2A CLINICAL TRIAL EXPECTED IN FIRST HALF OF 2026 - SEC FILINGSource text: [ID:n0001104659-26-001097]Further company coverage: RNAZ.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y617G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"gpt_icon":0},{"id":"2601971978","title":"Transcode Therapeutics Inc - Ttx-Mc138 Phase 2a Clinical Trial Expected in First Half of 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601971978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601971978?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:07","pubTimestamp":1767704849,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y617G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"gpt_icon":0},{"id":"2601976228","title":"TransCode Therapeutics Reports Preclinical Success of TTX-MC138 in Glioblastoma Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2601976228","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601976228?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:02","pubTimestamp":1767704568,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has announced the publication of preclinical research supporting the therapeutic potential of its lead candidate, TTX-MC138, for the treatment of glioblastoma multiforme . The study, published in the Journal of Functional Biomaterials, demonstrates that TTX-MC138, delivered intravenously, effectively targets glioblastoma tumors in murine models and suppresses the miR-10b target, resulting in extended survival in aggressive glioblastoma models. The findings support the clinical development of TTX-MC138 for GBM patients. Preclinical studies, including pharmacokinetics, biodistribution, and toxicity assessments, have been completed, and the formulation has shown safety in Phase I clinical trials in patients with non-CNS cancers. A Phase 1a clinical trial is currently evaluating TTX-MC138 in metastatic disease, with a Phase 2a trial anticipated to begin in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative art","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL2kDv9H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2593536443","title":"TransCode Therapeutics Files Amended 8-K on ABCJ Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2593536443","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593536443?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:16","pubTimestamp":1766524594,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has issued an amendment to its current report, providing updated financial statements and details regarding its recent acquisition of 100% of the membership interests of ABCJ, LLC for $125,000. The amendment includes information on subsequent events, including TransCode's commitment to provide adequate funding to meet ABCJ, LLC's financial obligations for the next 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3ggrW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2593453376","title":"Transcode Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Jack E. Stover","url":"https://stock-news.laohu8.com/highlight/detail?id=2593453376","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593453376?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:39","pubTimestamp":1766439585,"startTime":"0","endTime":"0","summary":"Transcode Therapeutics Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Jack E. Stover as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL5DyK53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Transcode Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Jack E. Stover","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2593487015","title":"Transcode Therapeutics Expands Leadership With Appointment of Jack E. Stover to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487015","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487015?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:01","pubTimestamp":1766408460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA7QGJQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2593948701","title":"Press Release: TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2593948701","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593948701?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:01","pubTimestamp":1766408460,"startTime":"0","endTime":"0","summary":"BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. , a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, announced the appointment of Jack E. Stover to its Board of Directors. Mr, Stover will join the Audit and the Nominating Committees as Dr. Magda Marquet steps down from the Audit Committee.  Mr. Stover brings more than three decades of executive leadership experience across public and private life sciences companies, spanning drug development, diagnostics, specialty pharmaceuticals, and capital formation.\"We are delighted to welcome Jack to TransCode's Board of Directors,\" said Philippe P. Calais, CEO, TransCode Therapeutics. \"Jack's wide and unique operational, financial, and strategic expertise -- as well as his successes leading through transformative growth -- will be a powerful asset as TransCode advances its RNA and immuno-oncology pipeline.\". This release contains \"forward-looking statements\" within t","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2591813786","title":"Transcode Therapeutics Inc Files for Mixed Shelf of up to $150 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591813786","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591813786?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:17","pubTimestamp":1765574279,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XI0QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2590351652","title":"TransCode Therapeutics and Quantum Leap Launch Phase 2a Trial for TTX-MC138 in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590351652","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590351652?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458332,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has announced a new collaboration with Quantum Leap Healthcare Collaborative to evaluate its lead therapeutic candidate, TTX-MC138, as part of the Quantum Leap PRE-I-SPY clinical trial platform. The partnership will launch a Phase 2a dose-expansion clinical trial enrolling up to 45 colorectal cancer patients who are ctDNA positive after standard curative-intent therapy. The trial aims to assess the biological and clinical activity of TTX-MC138 in the Minimal Residual Disease setting, with the goal of improving long-term outcomes and preventing cancer recurrence. This collaboration is expected to accelerate the development of effective, less toxic precision therapies for cancer patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6618CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"gpt_icon":0},{"id":"2590516527","title":"Transcode Therapeutics Inc - Phase 2a Trial to Begin in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590516527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590516527?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA9M9ZHZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2584952625","title":"BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584952625","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584952625?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:05","pubTimestamp":1763384708,"startTime":"0","endTime":"0","summary":"BRIEF-Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development OfficerTranscode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS EXPANDS EXECUTIVE TEAM ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUABLFKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2584625347","title":"Transcode Therapeutics Expands Executive Team With Appointment of DR. Michel Janicot as Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625347?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUABLFKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2584762597","title":"Press Release: TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584762597","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584762597?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:01","pubTimestamp":1763384460,"startTime":"0","endTime":"0","summary":"Accomplished drug development leader to advance TransCode's mission of defeating cancer through RNA innovation and translational excellence. BOSTON, Nov. 17, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. , an immuno-oncology and targeted cancer therapy company with a focus on treating advanced malignancy, announced today the appointment of Dr. Michel Janicot, Ph.D., as consultant Senior Development Officer. Dr. Janicot brings more than 35 years of experience in pharmaceutical research, preclinical, and early clinical drug development across oncology and other therapeutic areas. He will serve initially on a part-time basis.\"Michel's extensive leadership in drug development will strengthen and guide our efforts as TransCode advances its growing oncology pipeline,\" said Philippe P. Calais, Chief Executive Officer of TransCode Therapeutics. \"His expertise in RNA biology and oncology strategy will be instrumental in advancing TTX-MC138 and Seviprotimut-L-- our two lead programs in our m","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TISI","BK4539","RNAZ","BK4120"],"gpt_icon":0},{"id":"2578642369","title":"TransCode Therapeutics Amends Preferred Stock Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2578642369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578642369?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:28","pubTimestamp":1761571718,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has provided an update. On October 27, 2025, TransCode Therapeutics amended and restated its Certificate of Desi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-amends-preferred-stock-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-amends-preferred-stock-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ"],"gpt_icon":0},{"id":"2576663064","title":"TransCode Therapeutics Updates SEC Filing to Report CVR Agreement Effective Date and Change in Rights Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2576663064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576663064?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:09","pubTimestamp":1760735376,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. has filed Amendment No. 2 to its Current Report on Form 8-K to report the effective date of its Contingent Value Rights  Agreement and to note a change in the rights agent. The executed CVR Agreement with Vstock Transfer, LLC is included as an exhibit in the filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL3SPFgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}]}}